Jacob D Jones1, Michael Marsiske2, Michael S Okun3, Dawn Bowers1. 1. Department of Clinical and Health Psychology, McKnight Brain Institute, University of Florida. 2. Department of Clinical and Health Psychology, University of Florida. 3. Department of Neurology, McKnight Brain Institute, University of Florida.
Abstract
OBJECTIVE: Parkinson's disease (PD) is a neurodegenerative disorder resulting in a wide variety of symptoms. The current study examined the influence of apathy, depression and motor symptoms on quality of life (QoL) in PD patients. Information was drawn from an 18-month period. METHOD: Participants (N = 397) were assessed for apathy (Apathy Scale; Starkstein et al., 1992), depression (Beck Depression Inventory-II; Beck, Steer, Ball & Ranieri, 1996), motor severity (Unified Parkinson's Disease Rating Scale, Part III; UPDRS; Fahn, Elton & Committee, 1987), and QoL (Parkinson's Disease Questionnaire-39; Jenkinson, Fitzpatrick, Peto, Greenhall, & Hyman,1997) at 3 time points: an initial clinical evaluation (baseline), a 6-month follow-up, and an 18-month follow-up. Latent growth-curve models were used to determine the influence of apathy, depression, and motor symptoms on QoL trajectories. RESULTS: Greater difficulties with QoL at baseline showed the strongest relationship to more severe depression symptoms, followed by more severe motor symptoms, younger age, and less education (all p values < .001). Worsening of QoL over the 18-month period was only predicted by a worsening of depression (p = .003). The relationship between QoL and depression symptoms remained significant in a subsample of nondepressed PD patients. CONCLUSION: Overall, findings from the current study suggest that self-reported QoL among PD patients is primarily related to depression. Future efforts to improving clinical care of PD patients may benefit by focusing on improving psychosocial adjustment or treatments targeting depression. (c) 2015 APA, all rights reserved).
OBJECTIVE:Parkinson's disease (PD) is a neurodegenerative disorder resulting in a wide variety of symptoms. The current study examined the influence of apathy, depression and motor symptoms on quality of life (QoL) in PDpatients. Information was drawn from an 18-month period. METHOD:Participants (N = 397) were assessed for apathy (Apathy Scale; Starkstein et al., 1992), depression (Beck Depression Inventory-II; Beck, Steer, Ball & Ranieri, 1996), motor severity (Unified Parkinson's Disease Rating Scale, Part III; UPDRS; Fahn, Elton & Committee, 1987), and QoL (Parkinson's Disease Questionnaire-39; Jenkinson, Fitzpatrick, Peto, Greenhall, & Hyman,1997) at 3 time points: an initial clinical evaluation (baseline), a 6-month follow-up, and an 18-month follow-up. Latent growth-curve models were used to determine the influence of apathy, depression, and motor symptoms on QoL trajectories. RESULTS: Greater difficulties with QoL at baseline showed the strongest relationship to more severe depression symptoms, followed by more severe motor symptoms, younger age, and less education (all p values < .001). Worsening of QoL over the 18-month period was only predicted by a worsening of depression (p = .003). The relationship between QoL and depression symptoms remained significant in a subsample of nondepressed PDpatients. CONCLUSION: Overall, findings from the current study suggest that self-reported QoL among PDpatients is primarily related to depression. Future efforts to improving clinical care of PDpatients may benefit by focusing on improving psychosocial adjustment or treatments targeting depression. (c) 2015 APA, all rights reserved).
Authors: Laura B Zahodne; Michael Marsiske; Michael S Okun; Ramon L Rodriguez; Irene Malaty; Dawn Bowers Journal: Neuropsychology Date: 2011-12-05 Impact factor: 3.295
Authors: Jennifer Merrilees; Glenna A Dowling; Erin Hubbard; Judy Mastick; Robin Ketelle; Bruce L Miller Journal: Alzheimer Dis Assoc Disord Date: 2013 Jan-Mar Impact factor: 2.703
Authors: Jacob D Jones; London C Butterfield; Woojin Song; Jacob Lafo; Paul Mangal; Michael S Okun; Dawn Bowers Journal: J Neuropsychiatry Clin Neurosci Date: 2014-10-31 Impact factor: 2.198
Authors: Dennis J Zgaljardic; Joan C Borod; Nancy S Foldi; Mary Rocco; Paul J Mattis; Mark F Gordon; Andrew S Feigin; David Eidelberg Journal: Cogn Behav Neurol Date: 2007-09 Impact factor: 1.600
Authors: Jacob D Jones; Natalie E Kurniadi; Taylor P Kuhn; Sarah M Szymkowicz; Joseph Bunch; Elizabeth Rahmani Journal: Neuropsychology Date: 2019-07-25 Impact factor: 3.295
Authors: Sarah M Szymkowicz; Vonetta M Dotson; Jacob D Jones; Michael S Okun; Dawn Bowers Journal: J Int Neuropsychol Soc Date: 2017-10-16 Impact factor: 2.892
Authors: Jacob D Jones; Taylor Kuhn; Andrew Levine; Ned Sacktor; Cynthia A Munro; Linda A Teplin; Gypsyamber D'Souza; Eileen M Martin; James T Becker; Eric N Miller; Charles H Hinkin Journal: Neuropsychology Date: 2019-03 Impact factor: 3.424
Authors: Jacob D Jones; Taylor Kuhn; Zanjbeel Mahmood; Elyse J Singer; Charles H Hinkin; April D Thames Journal: Neuropsychology Date: 2017-09-11 Impact factor: 3.424